ARK BIO
Ark is an end-to-end solution provider focused on cancer early detection. By harnessing advanced data science and proprietary miRNA detection technology, Ark develops non-invasive and cost-effective blood tests to detect early stage cancers before clinical symptoms appear. The company collaborates extensively with top medical research institutions globally and is spearheading Asia’s largest miRNA clinical studies targeting more than 50,000 participants. Ark is headquartered in Singapore, with R&D, manufacturing and clinical diagnostic operations in China and USA.
ARK BIO
Social Links:
Industry:
Biotechnology Medical
Founded:
2018-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.ark.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Digital Ocean
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Creative Biosciences
Creative Biosciences is a biomedical technology company.
Enterin
Philadelphia-based biotechnology company .
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Magikare
Magikare is a medical technology innovation company.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Employees Featured
Founder
Investors List
Venturecraft Group
Venturecraft Group investment in Series A - Ark Bio
Gaorong Capital
Gaorong Capital investment in Series A - Ark Bio
Official Site Inspections
http://www.ark.bio
- Host name: 128.199.176.54
- IP address: 128.199.176.54
- Location: Singapore
- Latitude: 1.314
- Longitude: 103.6839
- Timezone: Asia/Singapore
- Postal: 62
More informations about "Ark Bio"
Ark Biotech - Crunchbase Company Profile & Funding
With an intelligent bioprocess platform, Ark helps today’s innovators make better decisions and accelerate development timelines dramatically — to bring transformational science to those who need it most. ... 9,932 Number of …See details»
This startup is trying to solve lab-grown meat’s biggest …
Apr 26, 2024 To help cultivated meat companies scale up, Ark Biotech has built a new kind of bioreactor, and its most valuable components are data — and air. The challenge: Lab-grown, cultivated, cultured, or clean — whatever you call …See details»
Ark Biotech
By using advanced multiphysics models that capture the complex dynamics of upstream cell culture, Ark turns convoluted data into actionable insights for real-world impact. Ark is fundamentally transforming how bioprocess is performed …See details»
ArkBio Company Profile 2024: Valuation, Funding
ArkBio General Information Description. Developer of innovative medicines designed to treat pediatric, respiratory, and lung diseases. The company's medicine is created to address unmet medical needs in the area of respiratory …See details»
Ark Bio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 27, 2018: Series A - Ark …See details»
Ark Biotech Company Profile 2024: Valuation, Funding ... - PitchBook
Ark Biotech was founded in 2021. Where is Ark Biotech headquartered? Ark Biotech is headquartered in Cambridge, MA. What is the size of Ark Biotech? Ark Biotech has 17 total …See details»
Ark Bio | Company | Mindmaps
Ark Bio Company. Ark is an end-to-end solution provider focused on cancer early detection. By harnessing advanced data science and proprietary miRNA detection technology, Ark develops …See details»
Ark Biopharmaceutical Enters Into Exclusive License ... - Ark …
SHANGHAI, December 28, 2021 -- Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”), an innovative biopharmaceutical company with a depth of expertise in pediatric drug …See details»
Ark Biotech: TEA Demonstrates How New …
Jul 11, 2023 Ark Biotech is a US B2B company supplying the cultivated meat industry with industrial-scale bioreactors, operating systems, and services. Based in Westwood, Massachusetts, the company was founded in 2021 by Yossi …See details»
Ark Bio Company Profile: Funding, Investors & Partnerships
Oct 15, 2022 Ark Bio. Submit feedback Claim this profile. Ark is an end-to-end solution provider focused on cancer early detection. By harnessing advanced data science and proprietary …See details»
ArkBio Announces Completion of Patient Enrollment and Dosing …
SHANGHAI, China, Jan. 25, 2022 (GLOBE NEWSWIRE) -- On January 25, 2022, Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced the completion of patient enrollment and …See details»
Ark Biosciences - Crunchbase Company Profile & Funding
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area …See details»
ArkBio's ex-Roche antiviral hits primary goal in RSV phase 3, …
Apr 7, 2022 Ark Biopharmaceutical’s bet on one of the less congested parts of the respiratory syncytial virus (RSV) space has delivered phase 3 results. Having picked up an antiviral …See details»
ArkBio Announces Completion of Patient Enrollment and
SHANGHAI, China, Jan. 25, 2022 (GLOBE NEWSWIRE) -- On January 25, 2022, Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced the completion of patient enrollment and …See details»
Ark Bio shares positive data for first positive RSV antiviral phase III
Apr 8, 2022 Ark Biopharmaceutical Co. Ltd.’s phase III testing its ziresovir in infants hospitalized with respiratory syncytial virus (RSV) infection produced positive top-line results, meeting both …See details»
Ark Bio - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Ark Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... including Chairman Too Heng-Phon. …See details»
ARKG - Genomic Revolution ETF by ARK Invest | ark-funds.com
Fund Objective. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its …See details»
Cathie Wood on Ark Strategy for Synthetic Biology, Biotech …
Nov 9, 2021 Biotech has always been part of Ark's investment strategy. Ark launched its genomics exchange-traded fund in 2014, the same year the firm was founded. Advertisement.See details»
Genomic Revolution Investment Strategy by ARK Invest
©2021-2026, ARK Investment Management LLC (“ARK” ® ”ARK Invest”). All content is original and has been researched and produced by ARK unless otherwise stated. No part of ARK’s …See details»